Diagnostic pathway and stage migration of sinonasal malignancies in the era of the COVID‐19 pandemic
Abstract Objectives The COVID‐19 pandemic bears the risk of delayed cancer diagnoses. Methods Study on the diagnostic pathway of sinonasal malignancies during the COVID‐19 pandemic. Results Median time from first symptom to treatment initiation was not increased during the pandemic: 137 days (interq...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-10-01
|
| Series: | Laryngoscope Investigative Otolaryngology |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/lio2.640 |
| _version_ | 1819241092426498048 |
|---|---|
| author | Christian M. Meerwein Thomas M. Stadler Panagiotis Balermpas Michael B. Soyka David Holzmann |
| author_facet | Christian M. Meerwein Thomas M. Stadler Panagiotis Balermpas Michael B. Soyka David Holzmann |
| author_sort | Christian M. Meerwein |
| collection | DOAJ |
| description | Abstract Objectives The COVID‐19 pandemic bears the risk of delayed cancer diagnoses. Methods Study on the diagnostic pathway of sinonasal malignancies during the COVID‐19 pandemic. Results Median time from first symptom to treatment initiation was not increased during the pandemic: 137 days (interquartile range [IQR] 104‐193) vs 139 days (IQR 103‐219) (P = .60). Median time from first appointment at our institution to treatment initiation was even reduced in 2020: 18 days (IQR 11‐25) vs 11 days (IQR 7‐17) (P = .02). A trend toward advanced tumor stages during the pandemic was seen: 11/30 patients (36.7%) ≥ stage 4 in 2018 to 2019 vs 12/19 patients (63.2%) ≥ stage 4 in 2020 (P = .064). Conclusion Both, time to diagnosis and time to treatment initiation were similar during the pandemic. However, a higher proportion of advanced tumors stages was observed. Despite the pandemic, we provided a swift diagnostic workflow, including a virtual tumor board decision and a prompt treatment initiation. Level of Evidence: 4. |
| first_indexed | 2024-12-23T14:18:25Z |
| format | Article |
| id | doaj.art-bb129f8c4f6b42f1bc798068a2b4aedd |
| institution | Directory Open Access Journal |
| issn | 2378-8038 |
| language | English |
| last_indexed | 2024-12-23T14:18:25Z |
| publishDate | 2021-10-01 |
| publisher | Wiley |
| record_format | Article |
| series | Laryngoscope Investigative Otolaryngology |
| spelling | doaj.art-bb129f8c4f6b42f1bc798068a2b4aedd2022-12-21T17:43:52ZengWileyLaryngoscope Investigative Otolaryngology2378-80382021-10-016590491010.1002/lio2.640Diagnostic pathway and stage migration of sinonasal malignancies in the era of the COVID‐19 pandemicChristian M. Meerwein0Thomas M. Stadler1Panagiotis Balermpas2Michael B. Soyka3David Holzmann4Department of Otorhinolaryngology, Head & Neck Surgery University Hospital Zurich Zurich SwitzerlandDepartment of Otorhinolaryngology, Head & Neck Surgery University Hospital Zurich Zurich SwitzerlandUniversity of Zurich Zurich SwitzerlandDepartment of Otorhinolaryngology, Head & Neck Surgery University Hospital Zurich Zurich SwitzerlandDepartment of Otorhinolaryngology, Head & Neck Surgery University Hospital Zurich Zurich SwitzerlandAbstract Objectives The COVID‐19 pandemic bears the risk of delayed cancer diagnoses. Methods Study on the diagnostic pathway of sinonasal malignancies during the COVID‐19 pandemic. Results Median time from first symptom to treatment initiation was not increased during the pandemic: 137 days (interquartile range [IQR] 104‐193) vs 139 days (IQR 103‐219) (P = .60). Median time from first appointment at our institution to treatment initiation was even reduced in 2020: 18 days (IQR 11‐25) vs 11 days (IQR 7‐17) (P = .02). A trend toward advanced tumor stages during the pandemic was seen: 11/30 patients (36.7%) ≥ stage 4 in 2018 to 2019 vs 12/19 patients (63.2%) ≥ stage 4 in 2020 (P = .064). Conclusion Both, time to diagnosis and time to treatment initiation were similar during the pandemic. However, a higher proportion of advanced tumors stages was observed. Despite the pandemic, we provided a swift diagnostic workflow, including a virtual tumor board decision and a prompt treatment initiation. Level of Evidence: 4.https://doi.org/10.1002/lio2.640delaymalignancynasal vestibule carcinomanasopharyngeal carcinomapandemicsinonasal |
| spellingShingle | Christian M. Meerwein Thomas M. Stadler Panagiotis Balermpas Michael B. Soyka David Holzmann Diagnostic pathway and stage migration of sinonasal malignancies in the era of the COVID‐19 pandemic Laryngoscope Investigative Otolaryngology delay malignancy nasal vestibule carcinoma nasopharyngeal carcinoma pandemic sinonasal |
| title | Diagnostic pathway and stage migration of sinonasal malignancies in the era of the COVID‐19 pandemic |
| title_full | Diagnostic pathway and stage migration of sinonasal malignancies in the era of the COVID‐19 pandemic |
| title_fullStr | Diagnostic pathway and stage migration of sinonasal malignancies in the era of the COVID‐19 pandemic |
| title_full_unstemmed | Diagnostic pathway and stage migration of sinonasal malignancies in the era of the COVID‐19 pandemic |
| title_short | Diagnostic pathway and stage migration of sinonasal malignancies in the era of the COVID‐19 pandemic |
| title_sort | diagnostic pathway and stage migration of sinonasal malignancies in the era of the covid 19 pandemic |
| topic | delay malignancy nasal vestibule carcinoma nasopharyngeal carcinoma pandemic sinonasal |
| url | https://doi.org/10.1002/lio2.640 |
| work_keys_str_mv | AT christianmmeerwein diagnosticpathwayandstagemigrationofsinonasalmalignanciesintheeraofthecovid19pandemic AT thomasmstadler diagnosticpathwayandstagemigrationofsinonasalmalignanciesintheeraofthecovid19pandemic AT panagiotisbalermpas diagnosticpathwayandstagemigrationofsinonasalmalignanciesintheeraofthecovid19pandemic AT michaelbsoyka diagnosticpathwayandstagemigrationofsinonasalmalignanciesintheeraofthecovid19pandemic AT davidholzmann diagnosticpathwayandstagemigrationofsinonasalmalignanciesintheeraofthecovid19pandemic |